After 3 initial monthly injections, current dosing intervals range from every 8 to 16 weeks in patients with wAMD and DME and every 8 to 12 weeks in patients with DR.

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...

Standard dosing algorithms could be responsible for the higher rates of thyrotoxicosis among older women vs men prescribed levoythroxine.